Artivion (AORT)
(Real Time Quote from BATS)
$25.28 USD
+0.13 (0.52%)
Updated Aug 8, 2024 01:51 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
AORT 25.28 +0.13(0.52%)
Will AORT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AORT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AORT
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates
AORT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates
Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
Other News for AORT
Artivion to Participate in Upcoming Investor Conferences
Lake Street Sticks to Their Buy Rating for Artivion (AORT)
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
Next Century Growth Investors Q2 2024 Commentary
Artivion Amends Agreements with Endospan